<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Sci (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Med Sci (Basel)</journal-id><journal-id journal-id-type="publisher-id">medsci</journal-id><journal-title-group><journal-title>Medical Sciences</journal-title></journal-title-group><issn pub-type="epub">2076-3271</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7151617</article-id><article-id pub-id-type="doi">10.3390/medsci8010009</article-id><article-id pub-id-type="publisher-id">medsci-08-00009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4361-8498</contrib-id><name><surname>Rawla</surname><given-names>Prashanth</given-names></name><xref ref-type="aff" rid="af1-medsci-08-00009">1</xref><xref rid="c1-medsci-08-00009" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Raj</surname><given-names>Jeffrey Pradeep</given-names></name><xref ref-type="aff" rid="af2-medsci-08-00009">2</xref></contrib><contrib contrib-type="author"><name><surname>Kannemkuzhiyil</surname><given-names>Alan Jose</given-names></name><xref ref-type="aff" rid="af3-medsci-08-00009">3</xref></contrib><contrib contrib-type="author"><name><surname>Aluru</surname><given-names>John Sukumar</given-names></name><xref ref-type="aff" rid="af4-medsci-08-00009">4</xref></contrib><contrib contrib-type="author"><name><surname>Thandra</surname><given-names>Krishna Chaitanya</given-names></name><xref ref-type="aff" rid="af5-medsci-08-00009">5</xref></contrib><contrib contrib-type="author"><name><surname>Gajendran</surname><given-names>Mahesh</given-names></name><xref ref-type="aff" rid="af6-medsci-08-00009">6</xref></contrib></contrib-group><aff id="af1-medsci-08-00009"><label>1</label>Department of Medicine, Sovah Health, Martinsville, VA 24112, USA</aff><aff id="af2-medsci-08-00009"><label>2</label>Department of Clinical Pharmacology, Seth G.S. Medical College &#x00026; King Edward Memorial Hospital, Mumbai 400012, India; <email>jpraj.m07@gmail.com</email></aff><aff id="af3-medsci-08-00009"><label>3</label>St. Johns Medical College, St. John&#x02019;s National Academy of Health Sciences, Bengaluru, Karnataka 560034, India; <email>alanjosekannemkuzhiyil@gmail.com</email></aff><aff id="af4-medsci-08-00009"><label>4</label>Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02212, USA; <email>Jaluru@bidmc.harvard.edu</email></aff><aff id="af5-medsci-08-00009"><label>5</label>Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA 23454, USA; <email>kc_thandra@yahoo.com</email></aff><aff id="af6-medsci-08-00009"><label>6</label>Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, Paul L. Foster School of Medicine, El Paso, TX 79905, USA; <email>mahesh.gajendran@ttuhsc.edu</email></aff><author-notes><corresp id="c1-medsci-08-00009"><label>*</label>Correspondence: <email>rawlap@gmail.com</email>; Tel.: +1-732-982-7357</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>9</elocation-id><history><date date-type="received"><day>04</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>1</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Hepatitis E virus (HEV) is a non-enveloped, positive-sense, single-stranded RNA icosahedral virus belongs to the genus <italic>Orthohepevirus</italic> within the Hepeviridae family. HEV infection can be asymptomatic, or it can cause icteric or fulminant hepatitis. Off late, there have been a number of publications reporting the extra-hepatic manifestations of HEV infection, and this systematic review is aimed at summarizing the available evidence in this regard. Two independent investigators searched PubMed, PubMed Central and Embase databases using the search string &#x0201c;(((hepatitis E) AND (Extrahepatic OR Extra-Hepatic))) OR ((Hepatitis E) AND (Neurology OR Cardiology OR Respiratory OR Lung OR Gastrointestinal OR musculoskeletal OR immunology OR pulmonary)) Filters: Abstract availability, English language, and Human studies&#x0201d;. The extra-hepatic manifestations reported in each of the selected articles were classified and reported as neurological, cardiovascular, and hematological and miscellaneous manifestations. The total number of various manifestations reported in our study were <italic>n</italic> = 324. These include neurological manifestations (<italic>n</italic> = 178/324 (54.94%)), cardiovascular and hematological manifestations (<italic>n</italic> = 113/324 (34.88%)), gastro-intestinal/pancreaticobiliary manifestations (<italic>n</italic> = 24/324 (7.41%)) and other rarer manifestations involving systems such as renal (<italic>n</italic> = 4/324; 1.24%), endocrine (<italic>n</italic> = 1/324; 0.31%), dermatology (<italic>n</italic> = 1/324; 0.31%), respiratory (<italic>n</italic> = 1/324; 0.31%), muscular (<italic>n</italic> = 1/324; 0.31%) and immune system (<italic>n</italic> = 1/324; 0.31%). Thus, HEV can have extra-hepatic manifestations affecting any system of the human body. Further research is needed to elucidate the underlying pathophysiological manifestations of these extra-hepatic manifestations and to prove causal association with HEV.</p></abstract><kwd-group><kwd>hepatitis E</kwd><kwd>HEV</kwd><kwd>viral hepatitis</kwd><kwd>extra-hepatic manifestations</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-medsci-08-00009"><title>1. Introduction</title><p>Hepatitis E virus (HEV) is a non-enveloped, positive-sense, single-stranded RNA icosahedral virus that belongs to the <italic>Orthohepevirus</italic> within the Hepeviridae family. Transmission of HEV can occur through the fecal-oral route by contaminated food and water, transfusion of blood, and through mother-to-child vertical transmission. Although person-to-person transmission is uncommon, patients are infectious during fecal shedding [<xref rid="B1-medsci-08-00009" ref-type="bibr">1</xref>]. HEV is represented by one serotype and four main genotypes wherein genotypes 1 and 2 spread via the fecal&#x02013;oral route and cause the epidemics, while genotypes 3 and 4 are zoonotic [<xref rid="B2-medsci-08-00009" ref-type="bibr">2</xref>]. Genotypes 1 and 2 are endemic in many developing nations. Genotype 1 is the most common cause of acute hepatitis in Asian countries, especially in India. Genotype 2 is seen commonly in Africa and Central America, Genotype 3 is prevalent in western countries, as well as in Asia and North America, while genotype 4 is detected in Asian and European countries [<xref rid="B3-medsci-08-00009" ref-type="bibr">3</xref>]. HEV infection is one of the most common causes of acute hepatitis globally with 20 million infections annually and an estimated 70,000 deaths attributed to genotypes 1 and 2 [<xref rid="B4-medsci-08-00009" ref-type="bibr">4</xref>].</p><p>HEV infection can be asymptomatic, or it can cause icteric or fulminant hepatitis [<xref rid="B5-medsci-08-00009" ref-type="bibr">5</xref>]. The seroprevalence of HEV was estimated at 6% in the USA, 11% in the UK, and 52% in the hyperendemic Toulouse region of south-west France in 2015 [<xref rid="B6-medsci-08-00009" ref-type="bibr">6</xref>]. A more recent meta-analysis of 2018 has shown that prevalence is up to 9% in the USA, 4.2% in Brazil and up to 1% in the Mixed Caribbean [<xref rid="B7-medsci-08-00009" ref-type="bibr">7</xref>]. Chronic HEV infection has also been reported, commonly associated with genotype 3, resulting in progressive liver failure, liver fibrosis, and cirrhosis [<xref rid="B8-medsci-08-00009" ref-type="bibr">8</xref>]. Of late, there have been a number of publications reporting the extra-hepatic manifestations of HEV infection, both acute and chronic, mainly due to the temporal association between the infection and the extra-hepatic manifestations after excluding the other possible etiologies that may mimic the manifestations. These extra-hepatic manifestations may thus distract the physician from diagnosing HEV infection, and this systematic review is aimed at summarizing the available evidence in this regard.</p></sec><sec sec-type="methods" id="sec2-medsci-08-00009"><title>2. Methods</title><p>Two independent investigators (JPR and AJK) searched PubMed, PubMed Central and Embase databases on 20th October 2018. The search string used in these databases were &#x0201c;(((hepatitis E) AND (Extrahepatic OR Extra-Hepatic))) OR ((Hepatitis E) AND (Neurology OR Cardiology OR Respiratory OR Lung OR Gastrointestinal OR musculoskeletal OR immunology OR pulmonary)) Filters: Abstract availability, English language, and Human studies&#x0201d;. Discrepancies between the two authors were adjudicated by another author (PRR). Review articles, letters to editors where abstract was not available and articles in whom the full text was not available were excluded. Finally, the extra-hepatic manifestations reported in each of the selected articles were classified and reported as neurological, cardiovascular, and hematological and miscellaneous manifestations.</p></sec><sec sec-type="results" id="sec3-medsci-08-00009"><title>3. Results</title><sec id="sec3dot1-medsci-08-00009"><title>3.1. Demographics</title><p>A total of 4215 articles (<italic>n</italic> = 1141 in PubMed; <italic>n</italic> = 2321 in PubMed Central and <italic>n</italic> = 753 in Embase) were retrieved based on the search strategy. After removing duplicates, articles unrelated to the objective, conference proceedings, unavailable full-texts, and non-English reports, the final number of articles included in this systematic review was <italic>n</italic> = 66. The PRISMA (preferred reporting items for systematic reviews and meta-analyses) flow diagram is given in <xref ref-type="fig" rid="medsci-08-00009-f001">Figure 1</xref>.</p><p>The total number of various manifestations reported in our study were <italic>N</italic> = 324. Neurological disorder was the most common extrahepatic manifestation of hepatitis E infection, with a total of <italic>n</italic> = 178/324 (54.94%) manifestations having been reported in our review. This was followed by the cardiovascular and hematological manifestations that accounted for <italic>n</italic> = 113/324 (34.88%) manifestations. The third common system involvement was the gastro-intestinal/pancreaticobiliary system that accounted for <italic>n</italic> = 24/324 (7.41%) manifestations. Rarer manifestations involving systems such as renal (<italic>n</italic> = 4/324; 1.24%), Endocrine (<italic>n</italic> = 1/324; 0.31%), Dermatology (<italic>n</italic> = 1/324; 0.31%), respiratory (<italic>n</italic> = 1/324; 0.31%), muscular (<italic>n</italic> = 1/324; 0.31%) and immune system (<italic>n</italic> = 1/324; 0.31%) were also reported.</p></sec><sec id="sec3dot2-medsci-08-00009"><title>3.2. Neurological and Musculoskeletal Manifestations</title><p>Among the neuro-muscular manifestations, the commonly reported were neuralgic amyotrophy (<italic>n</italic> = 102/179; 56.98%) [<xref rid="B9-medsci-08-00009" ref-type="bibr">9</xref>,<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>,<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>,<xref rid="B12-medsci-08-00009" ref-type="bibr">12</xref>,<xref rid="B13-medsci-08-00009" ref-type="bibr">13</xref>,<xref rid="B14-medsci-08-00009" ref-type="bibr">14</xref>,<xref rid="B15-medsci-08-00009" ref-type="bibr">15</xref>,<xref rid="B16-medsci-08-00009" ref-type="bibr">16</xref>,<xref rid="B17-medsci-08-00009" ref-type="bibr">17</xref>,<xref rid="B18-medsci-08-00009" ref-type="bibr">18</xref>,<xref rid="B19-medsci-08-00009" ref-type="bibr">19</xref>,<xref rid="B20-medsci-08-00009" ref-type="bibr">20</xref>,<xref rid="B21-medsci-08-00009" ref-type="bibr">21</xref>,<xref rid="B22-medsci-08-00009" ref-type="bibr">22</xref>,<xref rid="B23-medsci-08-00009" ref-type="bibr">23</xref>,<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>] and Guillain&#x02013;Barr&#x000e9; syndrome (<italic>n</italic> = 36/179; 20.11%) [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>,<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>,<xref rid="B25-medsci-08-00009" ref-type="bibr">25</xref>,<xref rid="B26-medsci-08-00009" ref-type="bibr">26</xref>,<xref rid="B27-medsci-08-00009" ref-type="bibr">27</xref>,<xref rid="B28-medsci-08-00009" ref-type="bibr">28</xref>,<xref rid="B29-medsci-08-00009" ref-type="bibr">29</xref>,<xref rid="B30-medsci-08-00009" ref-type="bibr">30</xref>,<xref rid="B31-medsci-08-00009" ref-type="bibr">31</xref>,<xref rid="B32-medsci-08-00009" ref-type="bibr">32</xref>,<xref rid="B33-medsci-08-00009" ref-type="bibr">33</xref>,<xref rid="B34-medsci-08-00009" ref-type="bibr">34</xref>,<xref rid="B35-medsci-08-00009" ref-type="bibr">35</xref>,<xref rid="B36-medsci-08-00009" ref-type="bibr">36</xref>,<xref rid="B37-medsci-08-00009" ref-type="bibr">37</xref>,<xref rid="B38-medsci-08-00009" ref-type="bibr">38</xref>,<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>,<xref rid="B40-medsci-08-00009" ref-type="bibr">40</xref>]. The other rarer neurological manifestations that were reported include mononeuritis multiplex [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>], encephalitis [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>,<xref rid="B13-medsci-08-00009" ref-type="bibr">13</xref>,<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>,<xref rid="B41-medsci-08-00009" ref-type="bibr">41</xref>], cerebral ischemia [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>,<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>], myasthenia gravis [<xref rid="B42-medsci-08-00009" ref-type="bibr">42</xref>], polyneuromyopathy [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>,<xref rid="B43-medsci-08-00009" ref-type="bibr">43</xref>], meningo-radiculitis [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>,<xref rid="B44-medsci-08-00009" ref-type="bibr">44</xref>], epilepsy [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>], encephalopathy [<xref rid="B45-medsci-08-00009" ref-type="bibr">45</xref>], facial nerve palsy [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>,<xref rid="B46-medsci-08-00009" ref-type="bibr">46</xref>,<xref rid="B47-medsci-08-00009" ref-type="bibr">47</xref>], encephalitic parkinsonism [<xref rid="B48-medsci-08-00009" ref-type="bibr">48</xref>], transverse myelitis [<xref rid="B49-medsci-08-00009" ref-type="bibr">49</xref>], peripheral neuropathy [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>,<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>,<xref rid="B50-medsci-08-00009" ref-type="bibr">50</xref>], vestibular neuritis [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>], small fiber neuropathy [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>], Myositis [<xref rid="B51-medsci-08-00009" ref-type="bibr">51</xref>], and certain non-specific neurological symptoms like myalgias, joint pains, etc. [<xref rid="B52-medsci-08-00009" ref-type="bibr">52</xref>,<xref rid="B53-medsci-08-00009" ref-type="bibr">53</xref>] which are summarized in <xref rid="medsci-08-00009-t001" ref-type="table">Table 1</xref>. </p></sec><sec id="sec3dot3-medsci-08-00009"><title>3.3. Cardiovascular and Hematological Manifestations</title><p>Among the cardiovascular and hematological manifestations, the commonly reported ones include cryoglobulinemia (<italic>n</italic> = 51/113; 45.13%) [<xref rid="B55-medsci-08-00009" ref-type="bibr">55</xref>] and monoclonal gammopathy (<italic>n</italic> = 17/113; 15.04%). [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>] The cardiovascular manifestations include myocarditis [<xref rid="B56-medsci-08-00009" ref-type="bibr">56</xref>,<xref rid="B57-medsci-08-00009" ref-type="bibr">57</xref>], cardiac arrhythmias [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>], long QT syndrome [<xref rid="B58-medsci-08-00009" ref-type="bibr">58</xref>], and Torsade&#x02019;s de pointes [<xref rid="B58-medsci-08-00009" ref-type="bibr">58</xref>]. The other hematological manifestations that were reported include anemia [<xref rid="B59-medsci-08-00009" ref-type="bibr">59</xref>], thrombocytopenia, [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>,<xref rid="B59-medsci-08-00009" ref-type="bibr">59</xref>] lymphocytosis, [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>] lymphopenia [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>], leukocytosis [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>], massive hemolysis [<xref rid="B61-medsci-08-00009" ref-type="bibr">61</xref>], metabolic acidosis [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>], and hematological malignancies [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>] which are summarized in <xref rid="medsci-08-00009-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec3dot4-medsci-08-00009"><title>3.4. Gastrointestinal/Pancreatico-Biliary and Miscellaneous Manifestations</title><p>With regards to the gastro-intestinal/pancreaticobiliary system, pancreatitis (<italic>n</italic> = 22/24; 91.67%) [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>,<xref rid="B62-medsci-08-00009" ref-type="bibr">62</xref>,<xref rid="B63-medsci-08-00009" ref-type="bibr">63</xref>,<xref rid="B64-medsci-08-00009" ref-type="bibr">64</xref>,<xref rid="B65-medsci-08-00009" ref-type="bibr">65</xref>,<xref rid="B66-medsci-08-00009" ref-type="bibr">66</xref>,<xref rid="B67-medsci-08-00009" ref-type="bibr">67</xref>] was the most common manifestation. One of these patients also had a pancreatic pseudocyst [<xref rid="B66-medsci-08-00009" ref-type="bibr">66</xref>]. The other manifestation reported from this system was acalculous cholecystitis [<xref rid="B68-medsci-08-00009" ref-type="bibr">68</xref>]. <xref rid="medsci-08-00009-t003" ref-type="table">Table 3</xref> summarizes the reports of manifestations of other systems such as endocrinology [<xref rid="B69-medsci-08-00009" ref-type="bibr">69</xref>], dermatology [<xref rid="B70-medsci-08-00009" ref-type="bibr">70</xref>], immunology [<xref rid="B71-medsci-08-00009" ref-type="bibr">71</xref>], renal [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>,<xref rid="B61-medsci-08-00009" ref-type="bibr">61</xref>] and respiratory [<xref rid="B72-medsci-08-00009" ref-type="bibr">72</xref>] whose frequencies of occurrence have been rare.</p></sec></sec><sec sec-type="discussion" id="sec4-medsci-08-00009"><title>4. Discussion</title><p>In this systematic review, we have summarized the frequencies of various neurological, cardiovascular, hematological, gastrointestinal and other systemic extra-hepatic manifestations of HEV infection that have been reported in the literature. We report that neurological manifestations are more common over the other manifestations, which are followed by the hematological manifestations. However, it is clear that any body system could be affected by HEV and can present with manifestations. HEV infection is a self-limiting illness lasting a few days with symptoms of hepatitis such as jaundice, fever, nausea, vomiting, abdominal pain, anorexia, and malaise [<xref rid="B75-medsci-08-00009" ref-type="bibr">75</xref>]. Mortality is greater in patients who are pregnant or have chronic liver disease [<xref rid="B75-medsci-08-00009" ref-type="bibr">75</xref>]. However, chronic infection has also been reported especially with genotype-3 [<xref rid="B75-medsci-08-00009" ref-type="bibr">75</xref>]. </p><p>Various extra-hepatic manifestations of HEV have been reported from time to time, and the neurological manifestations clearly take the lead. The acute inflammatory demyelinating polyradiculoneuropathy (AIDP) is the most common variant of HEV associated GBS (Guillain-Barre syndrome) [<xref rid="B76-medsci-08-00009" ref-type="bibr">76</xref>]. Whereas, in a vast majority of patients with neuralgic amyotrophy, the brachial plexus or the phrenic nerve was most commonly affected. These patients are thought to be genetically predisposed for an autoimmune response [<xref rid="B77-medsci-08-00009" ref-type="bibr">77</xref>] Though the pathophysiology behind these manifestations is largely unclear, three hypotheses have been put forth [<xref rid="B75-medsci-08-00009" ref-type="bibr">75</xref>,<xref rid="B76-medsci-08-00009" ref-type="bibr">76</xref>,<xref rid="B77-medsci-08-00009" ref-type="bibr">77</xref>], the first hypothesis being the presence of HEV quasi-species with the ability to infect neurologic tissues [<xref rid="B75-medsci-08-00009" ref-type="bibr">75</xref>,<xref rid="B77-medsci-08-00009" ref-type="bibr">77</xref>]. This is supported by the fact that HEV RNA had been isolated from the cerebrospinal fluid (CSF) of patients, and it was found to be different from that of the ones seen in the serum at the same time point, suggesting the presence of certain neurotropic variants [<xref rid="B52-medsci-08-00009" ref-type="bibr">52</xref>]. However, this has not always been the case wherein HEV RNA has not been isolated from the CSF [<xref rid="B38-medsci-08-00009" ref-type="bibr">38</xref>]. The second hypothesis being the ability of the virus to acquire host RNA sequences, thereby the property to infect multiple cell types including the CNS [<xref rid="B77-medsci-08-00009" ref-type="bibr">77</xref>]. The third one being the property of some strains to produce certain antigens which in turn leads to autoimmune inflammatory polyneuropathy via molecular mimicry [<xref rid="B76-medsci-08-00009" ref-type="bibr">76</xref>,<xref rid="B77-medsci-08-00009" ref-type="bibr">77</xref>]. In patients with neurological disorders especially peripheral nerve involvement and concurrent liver enzyme elevation it is recommended that clinicians consider the possibility of HEV infection.</p><p>The most striking hematological manifestation is cryoglobulinemia, and the pathophysiology is largely unknown. One hypothesis is that there may be an increased expression of serum B cell-activating factor (BAFF), a tumor necrosis factor (TNF)-&#x003b1; family member required for B cell survival that has been documented in certain autoimmune diseases and hepatitis C infection. Thus, cryoglobulinemia has been reported in conjunction with other autoimmune or inflammatory disorders [<xref rid="B78-medsci-08-00009" ref-type="bibr">78</xref>], especially in several other viral hepatitis including hepatitis C virus [<xref rid="B79-medsci-08-00009" ref-type="bibr">79</xref>]. Thus, for the association between cryoglobulinemia and HEV, it is possible that either HEV causes cryoglobulinemia whose mechanism is currently unknown, or pre-existing cryoglobulinemia weakens the immune system of the patient who subsequently acquires HEV infection [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]. The same could be true for the hematological malignancies, as well [<xref rid="B79-medsci-08-00009" ref-type="bibr">79</xref>]. Cryoglobulinemia, in turn, can cause renal injury and glomerulonephritis [<xref rid="B80-medsci-08-00009" ref-type="bibr">80</xref>]. Though thrombocytopenia could be due to autoimmune causes as in other viral infections [<xref rid="B81-medsci-08-00009" ref-type="bibr">81</xref>]. the changes in lymphocyte and platelet counts are most likely to be non-specific, found following inflammatory stimuli as these changes had no clinical consequences [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>].</p><p>With regards to pancreatitis, it was once thought to be mostly associated with fulminant hepatitis, but of late, this dictum has been proven to be wrong as more and more pancreatitis has been reported in patients without fulminant hepatitis [<xref rid="B81-medsci-08-00009" ref-type="bibr">81</xref>]. Like other extrahepatic manifestations, the underlying mechanism is largely unknown, and there are a few hypotheses. Some of these include biliary sludging in the early phase of viral illness, the development of edema of the hepatopancreatic ampulla (ampulla of Vater) and a resultant obstruction to the pancreatic fluid outflow, direct inflammation and destruction of pancreatic acinar cell by the virus, release of lysosomal enzymes from the inflamed liver along with the activation of trypsinogen to trypsin and rarely, intrapancreatic hemorrhage due to hypoprothrombinemia or disseminated intravascular coagulation resulting in pancreatic damage and subsequent pancreatitis [<xref rid="B81-medsci-08-00009" ref-type="bibr">81</xref>]. Thus, any patient with HEV and abdominal pain out of proportion should be evaluated for acute pancreatitis and conservatively managed [<xref rid="B81-medsci-08-00009" ref-type="bibr">81</xref>]. We have also reported a large number of other manifestations, which are much rarer and thus would require more case studies/reports and further research to prove their association with HEV.</p><p>Our study, however, has a few limitations. Our main limitation is that this is a review of studies indexed in just three databases and there is a likelihood that we have missed information that was published in non-indexed journals/conference proceedings.</p></sec><sec sec-type="conclusions" id="sec5-medsci-08-00009"><title>5. Conclusions</title><p>In this systematic review, we have made an attempt to summarize the plethora of extra-hepatic manifestations of HEV that have been reported as either case reports, case series, retrospective/prospective observational studies. These manifestations could affect any of the systems in our human body. We report that neurological manifestations (GBS or neuralgic amyotrophy) are the most common extrahepatic manifestations followed by cryoglobulinemia and other inconsequential hematological changes. Acute pancreatitis like in any other viral hepatitis is seen associated with HEV also. Further research is needed to elucidate the underlying pathophysiological manifestations of these extra-hepatic manifestations and to prove causal association with HEV.</p></sec></body><back><notes><title>Author Contributions</title><p>Conception and design: P.R., J.P.R., A.J.K.; analysis and interpretation, drafting and critical revision of the article: P.R., J.P.R., A.J.K., K.C.T., J.S.A., M.G.; final approval of the article: P.R., J.P.R., A.J.K., K.C.T., J.S.A., M.G. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The other authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-medsci-08-00009"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debing</surname><given-names>Y.</given-names></name><name><surname>Moradpour</surname><given-names>D.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Gouttenoire</surname><given-names>J.</given-names></name></person-group><article-title>Update on hepatitis E virology: Implications for clinical practice</article-title><source>J. Hepatol.</source><year>2016</year><volume>65</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.02.045</pub-id><?supplied-pmid 26966047?><pub-id pub-id-type="pmid">26966047</pub-id></element-citation></ref><ref id="B2-medsci-08-00009"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.-J.</given-names></name></person-group><article-title>Zoonotic and Foodborne Transmission of Hepatitis E Virus</article-title><source>Semin. Liver Dis.</source><year>2013</year><volume>33</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1338113</pub-id><?supplied-pmid 23564388?><pub-id pub-id-type="pmid">23564388</pub-id></element-citation></ref><ref id="B3-medsci-08-00009"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tengan</surname><given-names>F.M.</given-names></name><name><surname>Figueiredo</surname><given-names>G.M.</given-names></name><name><surname>Nunes</surname><given-names>A.K.S.</given-names></name><name><surname>Manchiero</surname><given-names>C.</given-names></name><name><surname>Dantas</surname><given-names>B.P.</given-names></name><name><surname>Magri</surname><given-names>M.C.</given-names></name><name><surname>Prata</surname><given-names>T.V.G.</given-names></name><name><surname>Nascimento</surname><given-names>M.</given-names></name><name><surname>Mazza</surname><given-names>C.C.</given-names></name><name><surname>Abdala</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Seroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysis</article-title><source>Infect. Dis. Poverty</source><year>2019</year><volume>8</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s40249-018-0514-4</pub-id><pub-id pub-id-type="pmid">30646964</pub-id></element-citation></ref><ref id="B4-medsci-08-00009"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rein</surname><given-names>D.B.</given-names></name><name><surname>Stevens</surname><given-names>G.A.</given-names></name><name><surname>Theaker</surname><given-names>J.</given-names></name><name><surname>Wittenborn</surname><given-names>J.S.</given-names></name><name><surname>Wiersma</surname><given-names>S.T.</given-names></name></person-group><article-title>The global burden of hepatitis E virus genotypes 1 and 2 in 2005</article-title><source>Hepatol.</source><year>2012</year><volume>55</volume><fpage>988</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1002/hep.25505</pub-id><?supplied-pmid 22121109?><pub-id pub-id-type="pmid">22121109</pub-id></element-citation></ref><ref id="B5-medsci-08-00009"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazerbachi</surname><given-names>F.</given-names></name><name><surname>Haffar</surname><given-names>S.</given-names></name></person-group><article-title>Acute fulminant vs. acute-on-chronic liver failure in hepatitis E: Diagnostic implications</article-title><source>Infect. Dis.</source><year>2015</year><volume>47</volume><fpage>112</fpage><pub-id pub-id-type="doi">10.3109/00365548.2014.968612</pub-id><?supplied-pmid 25390689?><pub-id pub-id-type="pmid">25390689</pub-id></element-citation></ref><ref id="B6-medsci-08-00009"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazerbachi</surname><given-names>F.</given-names></name><name><surname>Haffar</surname><given-names>S.</given-names></name><name><surname>Garg</surname><given-names>S.K.</given-names></name><name><surname>Lake</surname><given-names>J.R.</given-names></name></person-group><article-title>Extra-hepatic manifestations associated with hepatitis E virus infection: A comprehensive review of the literature</article-title><source>Gastroenterol. Rep.</source><year>2015</year><volume>4</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1093/gastro/gov042</pub-id><?supplied-pmid 26358655?><pub-id pub-id-type="pmid">26358655</pub-id></element-citation></ref><ref id="B7-medsci-08-00009"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvatits</surname><given-names>T.</given-names></name><name><surname>Ozga</surname><given-names>A.-K.</given-names></name><name><surname>Westh&#x000f6;lter</surname><given-names>D.</given-names></name><name><surname>Hartl</surname><given-names>J.</given-names></name><name><surname>Manthey</surname><given-names>C.F.</given-names></name><name><surname>L&#x000fc;tgehetmann</surname><given-names>M.</given-names></name><name><surname>Rauch</surname><given-names>G.</given-names></name><name><surname>Kriston</surname><given-names>L.</given-names></name><name><surname>Lohse</surname><given-names>A.W.</given-names></name><name><surname>Bendall</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Hepatitis E seroprevalence in the Americas: A systematic review and meta-analysis</article-title><source>Liver Int.</source><year>2018</year><volume>38</volume><fpage>1951</fpage><lpage>1964</lpage><pub-id pub-id-type="doi">10.1111/liv.13859</pub-id><pub-id pub-id-type="pmid">29660259</pub-id></element-citation></ref><ref id="B8-medsci-08-00009"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name></person-group><article-title>Chronic hepatitis e virus infection and treatment</article-title><source>J. Clin. Exp. Hepatol.</source><year>2013</year><volume>3</volume><fpage>134</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.jceh.2013.05.003</pub-id><pub-id pub-id-type="pmid">25755487</pub-id></element-citation></ref><ref id="B9-medsci-08-00009"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila</surname><given-names>J.D.</given-names></name><name><surname>Lacomis</surname><given-names>D.</given-names></name><name><surname>Lam</surname><given-names>E.M.</given-names></name></person-group><article-title>Neuralgic Amyotrophy Associated with Hepatitis E Virus Infection</article-title><source>J. Clin. Neuromuscul. Dis.</source><year>2016</year><volume>18</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1097/CND.0000000000000137</pub-id><pub-id pub-id-type="pmid">27861224</pub-id></element-citation></ref><ref id="B10-medsci-08-00009"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrin</surname><given-names>H.B.</given-names></name><name><surname>Cintas</surname><given-names>P.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Gerolami</surname><given-names>R.</given-names></name><name><surname>D&#x02019;Alteroche</surname><given-names>L.</given-names></name><name><surname>Raynal</surname><given-names>J.-N.</given-names></name><name><surname>Alric</surname><given-names>L.</given-names></name><name><surname>Dupuis</surname><given-names>E.</given-names></name><name><surname>Prudhomme</surname><given-names>L.</given-names></name><name><surname>Vaucher</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E</article-title><source>Emerg. Infect. Dis.</source><year>2015</year><volume>21</volume><fpage>1928</fpage><lpage>1934</lpage><pub-id pub-id-type="doi">10.3201/eid2111.141789</pub-id><pub-id pub-id-type="pmid">26490255</pub-id></element-citation></ref><ref id="B11-medsci-08-00009"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Van Eijk</surname><given-names>J.J.</given-names></name><name><surname>Cintas</surname><given-names>P.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>Jones</surname><given-names>C.</given-names></name><name><surname>Webb</surname><given-names>G.W.</given-names></name><name><surname>Norton</surname><given-names>B.</given-names></name><name><surname>Pique</surname><given-names>J.</given-names></name><name><surname>Lutgens</surname><given-names>S.</given-names></name><name><surname>Devooght-Johnson</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study</article-title><source>J. Hepatol.</source><year>2017</year><volume>67</volume><fpage>925</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2017.07.010</pub-id><?supplied-pmid 28734938?><pub-id pub-id-type="pmid">28734938</pub-id></element-citation></ref><ref id="B12-medsci-08-00009"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dartevel</surname><given-names>A.</given-names></name><name><surname>Colombe</surname><given-names>B.</given-names></name><name><surname>Bosseray</surname><given-names>A.</given-names></name><name><surname>Larrat</surname><given-names>S.</given-names></name><name><surname>Sarrot-Reynauld</surname><given-names>F.</given-names></name><name><surname>Belbezier</surname><given-names>A.</given-names></name><name><surname>Lagrange</surname><given-names>E.</given-names></name><name><surname>Bouillet</surname><given-names>L.</given-names></name></person-group><article-title>Hepatitis E and neuralgic amyotrophy: Five cases and review of literature</article-title><source>J. Clin. Virol.</source><year>2015</year><volume>69</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.06.091</pub-id><?supplied-pmid 26209399?><pub-id pub-id-type="pmid">26209399</pub-id></element-citation></ref><ref id="B13-medsci-08-00009"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deroux</surname><given-names>A.</given-names></name><name><surname>Brion</surname><given-names>J.</given-names></name><name><surname>Hyerle</surname><given-names>L.</given-names></name><name><surname>Belb&#x000e9;zier</surname><given-names>A.</given-names></name><name><surname>Vaillant</surname><given-names>M.</given-names></name><name><surname>Mosnier</surname><given-names>E.</given-names></name><name><surname>Larrat</surname><given-names>S.</given-names></name><name><surname>Morand</surname><given-names>P.</given-names></name><name><surname>Pavese</surname><given-names>P.</given-names></name></person-group><article-title>Association between hepatitis E and neurological disorders: Two case studies and literature review</article-title><source>J. Clin. Virol.</source><year>2014</year><volume>60</volume><fpage>60</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2014.01.026</pub-id><?supplied-pmid 24583064?><pub-id pub-id-type="pmid">24583064</pub-id></element-citation></ref><ref id="B14-medsci-08-00009"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>F.</given-names></name><name><surname>Illahi</surname><given-names>M.</given-names></name></person-group><article-title>Neuralgic amyotrophy associated with hepatitis E virus</article-title><source>Clin. Neurol. Neurosurg.</source><year>2009</year><volume>111</volume><fpage>193</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2008.09.005</pub-id><?supplied-pmid 18986757?><pub-id pub-id-type="pmid">18986757</pub-id></element-citation></ref><ref id="B15-medsci-08-00009"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>M.</given-names></name><name><surname>Berger</surname><given-names>B.</given-names></name><name><surname>Schemmerer</surname><given-names>M.</given-names></name><name><surname>Endres</surname><given-names>D.</given-names></name><name><surname>Wenzel</surname><given-names>J.J.</given-names></name><name><surname>Stich</surname><given-names>O.</given-names></name><name><surname>Panning</surname><given-names>M.</given-names></name></person-group><article-title>Pathological Cerebrospinal Fluid Findings in Patients with Neuralgic Amyotrophy and Acute Hepatitis E Virus Infection</article-title><source>J. Infect. Dis.</source><year>2018</year><volume>217</volume><fpage>1897</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy128</pub-id><pub-id pub-id-type="pmid">29547884</pub-id></element-citation></ref><ref id="B16-medsci-08-00009"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>K.</given-names></name><name><surname>Van Eijk</surname><given-names>J.</given-names></name><name><surname>Ripellino</surname><given-names>P.</given-names></name><name><surname>Madden</surname><given-names>R.</given-names></name><name><surname>Herrod</surname><given-names>J.</given-names></name><name><surname>Lissmann</surname><given-names>R.</given-names></name><name><surname>Webb</surname><given-names>G.</given-names></name><name><surname>Abdelrahim</surname><given-names>M.</given-names></name><name><surname>Ashraf</surname><given-names>H.</given-names></name><name><surname>Almasri</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study</article-title><source>J. Hepatol.</source><year>2017</year><volume>66</volume><fpage>S59</fpage><pub-id pub-id-type="doi">10.1016/S0168-8278(17)30380-X</pub-id></element-citation></ref><ref id="B17-medsci-08-00009"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azofra</surname><given-names>M.S.</given-names></name><name><surname>Portales</surname><given-names>M.R.</given-names></name><name><surname>Laureiro</surname><given-names>L.T.</given-names></name><name><surname>Garc&#x000ed;a-Samaniego</surname><given-names>J.</given-names></name><name><surname>Sanz</surname><given-names>P.M.</given-names></name></person-group><article-title>Hepatitis E virus in neurological disorders: a case of Parsonage-Turner syndrome</article-title><source>Revista Espa&#x000f1;ola de Enfermedades Digestivas</source><year>2018</year><volume>110</volume><fpage>402</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">29685043</pub-id></element-citation></ref><ref id="B18-medsci-08-00009"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanvion</surname><given-names>Q.</given-names></name><name><surname>Perez</surname><given-names>T.</given-names></name><name><surname>Cassim</surname><given-names>F.</given-names></name><name><surname>Outteryck</surname><given-names>O.</given-names></name><name><surname>Lanteri</surname><given-names>A.</given-names></name><name><surname>Hatron</surname><given-names>P.-Y.</given-names></name><name><surname>Lambert</surname><given-names>M.</given-names></name><name><surname>Morell-Dubois</surname><given-names>S.</given-names></name></person-group><article-title>Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype</article-title><source>J. Neurol.</source><year>2017</year><volume>264</volume><fpage>770</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1007/s00415-017-8433-z</pub-id><pub-id pub-id-type="pmid">28247042</pub-id></element-citation></ref><ref id="B19-medsci-08-00009"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>M.</given-names></name><name><surname>Wicki</surname><given-names>B.</given-names></name><name><surname>Tsouni</surname><given-names>P.</given-names></name><name><surname>Cunningham</surname><given-names>S.</given-names></name><name><surname>Doerig</surname><given-names>C.</given-names></name><name><surname>Zanetti</surname><given-names>G.</given-names></name><name><surname>Aubert</surname><given-names>V.</given-names></name><name><surname>Sahli</surname><given-names>R.</given-names></name><name><surname>Moradpour</surname><given-names>D.</given-names></name><name><surname>Kuntzer</surname><given-names>T.</given-names></name></person-group><article-title>Hepatitis E virus infection as a direct cause of neuralgic amyotrophy</article-title><source>Muscle Nerve</source><year>2016</year><volume>54</volume><fpage>325</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1002/mus.25096</pub-id><pub-id pub-id-type="pmid">26939568</pub-id></element-citation></ref><ref id="B20-medsci-08-00009"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swinnen</surname><given-names>B.</given-names></name><name><surname>Boeynaems</surname><given-names>S.</given-names></name><name><surname>Schrooten</surname><given-names>M.</given-names></name><name><surname>Saegeman</surname><given-names>V.</given-names></name><name><surname>Claeys</surname><given-names>K.G.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name></person-group><article-title>Anterior interosseous mononeuropathy associated with HEV infection</article-title><source>Neurol. Neuroimmunol. Neuroinflamm.</source><year>2018</year><volume>5</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1212/NXI.0000000000000429</pub-id></element-citation></ref><ref id="B21-medsci-08-00009"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theochari</surname><given-names>E.</given-names></name><name><surname>Vincent-Smith</surname><given-names>L.</given-names></name><name><surname>Ellis</surname><given-names>C.</given-names></name></person-group><article-title>Neuralgic amyotrophy complicating acute hepatitis E infection: a rare association</article-title><source>BMJ Case Rep.</source><year>2015</year><volume>2015</volume><fpage>2014</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1136/bcr-2014-207669</pub-id></element-citation></ref><ref id="B22-medsci-08-00009"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Eijk</surname><given-names>J.J.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>Van Der Eijk</surname><given-names>A.A.</given-names></name><name><surname>Hunter</surname><given-names>J.G.</given-names></name><name><surname>Reimerink</surname><given-names>J.H.</given-names></name><name><surname>Bendall</surname><given-names>R.P.</given-names></name><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Ellis</surname><given-names>V.</given-names></name><name><surname>Van Alfen</surname><given-names>N.</given-names></name><name><surname>Beynon</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Neuralgic amyotrophy and hepatitis E virus infection</article-title><source>Neurol.</source><year>2014</year><volume>82</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000112</pub-id><?supplied-pmid 24401685?><pub-id pub-id-type="pmid">24401685</pub-id></element-citation></ref><ref id="B23-medsci-08-00009"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velay</surname><given-names>A.</given-names></name><name><surname>Kack-Kack</surname><given-names>W.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Leyendecker</surname><given-names>P.</given-names></name><name><surname>Kremer</surname><given-names>L.</given-names></name><name><surname>Chamouard</surname><given-names>P.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Fafi-Kremer</surname><given-names>S.</given-names></name><name><surname>Barth</surname><given-names>H.</given-names></name></person-group><article-title>Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient</article-title><source>J. NeuroVirology</source><year>2017</year><volume>23</volume><fpage>615</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1007/s13365-017-0525-0</pub-id><?supplied-pmid 28439773?><pub-id pub-id-type="pmid">28439773</pub-id></element-citation></ref><ref id="B24-medsci-08-00009"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolson</surname><given-names>K.L.</given-names></name><name><surname>Forbes</surname><given-names>A.</given-names></name><name><surname>Vine</surname><given-names>L.</given-names></name><name><surname>Beynon</surname><given-names>L.</given-names></name><name><surname>McElhinney</surname><given-names>L.</given-names></name><name><surname>Panayi</surname><given-names>V.</given-names></name><name><surname>Hunter</surname><given-names>J.G.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>Glasgow</surname><given-names>T.</given-names></name><name><surname>Kotecha</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Extra-hepatic manifestations of autochthonous hepatitis E infection</article-title><source>Aliment. Pharmacol. Ther.</source><year>2014</year><volume>40</volume><fpage>1282</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1111/apt.12986</pub-id><?supplied-pmid 25303615?><pub-id pub-id-type="pmid">25303615</pub-id></element-citation></ref><ref id="B25-medsci-08-00009"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Saffar</surname><given-names>A.</given-names></name><name><surname>Al-Fatly</surname><given-names>B.</given-names></name></person-group><article-title>Acute Motor Axonal Neuropathy in Association with Hepatitis E</article-title><source>Front. Neurol.</source><year>2018</year><volume>9</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.3389/fneur.2018.00062</pub-id><?supplied-pmid 29479336?><pub-id pub-id-type="pmid">29403429</pub-id></element-citation></ref><ref id="B26-medsci-08-00009"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandyopadhyay</surname><given-names>D.</given-names></name><name><surname>Ganesan</surname><given-names>V.</given-names></name><name><surname>Choudhury</surname><given-names>C.</given-names></name><name><surname>Kar</surname><given-names>S.S.</given-names></name><name><surname>Karmakar</surname><given-names>P.</given-names></name><name><surname>Choudhary</surname><given-names>V.</given-names></name><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Bhar</surname><given-names>D.</given-names></name><name><surname>Hajra</surname><given-names>A.</given-names></name><name><surname>Layek</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Two Uncommon Causes of Guillain-Barr&#x000e9; Syndrome: Hepatitis E and Japanese Encephalitis</article-title><source>Case Rep. Neurol. Med.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1155/2015/759495</pub-id><?supplied-pmid 26798531?><pub-id pub-id-type="pmid">26798531</pub-id></element-citation></ref><ref id="B27-medsci-08-00009"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>M.C.</given-names></name><name><surname>Bajpai</surname><given-names>V.</given-names></name><name><surname>Anand</surname><given-names>L.</given-names></name><name><surname>Gupta</surname><given-names>E.</given-names></name></person-group><article-title>Guillain-Barr&#x000e9; syndrome in a patient of acute Hepatitis E virus infection associated with genotype 1: Case report and literature review</article-title><source>Intractable Rare Dis. Res.</source><year>2019</year><volume>8</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">30881857</pub-id></element-citation></ref><ref id="B28-medsci-08-00009"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronin</surname><given-names>S.</given-names></name><name><surname>McNicholas</surname><given-names>R.</given-names></name><name><surname>Kavanagh</surname><given-names>E.</given-names></name><name><surname>Reid</surname><given-names>V.</given-names></name><name><surname>O&#x02019;Rourke</surname><given-names>K.</given-names></name></person-group><article-title>Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection</article-title><source>Ir. J. Med. Sci.</source><year>2011</year><volume>180</volume><fpage>255</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1007/s11845-010-0635-7</pub-id><pub-id pub-id-type="pmid">21063804</pub-id></element-citation></ref><ref id="B29-medsci-08-00009"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukae</surname><given-names>J.</given-names></name><name><surname>Tsugawa</surname><given-names>J.</given-names></name><name><surname>Ouma</surname><given-names>S.</given-names></name><name><surname>Umezu</surname><given-names>T.</given-names></name><name><surname>Kusunoki</surname><given-names>S.</given-names></name><name><surname>Tsuboi</surname><given-names>Y.</given-names></name></person-group><article-title>Guillain&#x02013;Barr&#x000e9; and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan</article-title><source>Neurol. Sci.</source><year>2016</year><volume>37</volume><fpage>1849</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1007/s10072-016-2644-4</pub-id><pub-id pub-id-type="pmid">27389141</pub-id></element-citation></ref><ref id="B30-medsci-08-00009"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>M.</given-names></name><name><surname>Fukae</surname><given-names>J.</given-names></name><name><surname>Tsugawa</surname><given-names>J.</given-names></name><name><surname>Ouma</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Mishiro</surname><given-names>S.</given-names></name><name><surname>Tsuboi</surname><given-names>Y.</given-names></name></person-group><article-title>Dysgeusia in a Patient with Guillain-Barr&#x000e9; Syndrome Associated with Acute Hepatitis E: A Case Report and Literature Review</article-title><source>Intern. Med.</source><year>2015</year><volume>54</volume><fpage>1543</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.54.3506</pub-id><pub-id pub-id-type="pmid">26073247</pub-id></element-citation></ref><ref id="B31-medsci-08-00009"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>F.</given-names></name></person-group><article-title>Guillain&#x02013;Barre Syndrome Following Acute Co-Super-Infection of Hepatitis E Virus and Cytomegalovirus in a Chronic Hepatitis B Virus Carrier</article-title><source>J. Med. Virol.</source><year>2017</year><volume>19</volume><fpage>368</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1002/jmv.24620</pub-id><?supplied-pmid 27358107?><pub-id pub-id-type="pmid">27358107</pub-id></element-citation></ref><ref id="B32-medsci-08-00009"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loly</surname><given-names>J.P.</given-names></name><name><surname>Rikir</surname><given-names>E.</given-names></name><name><surname>Seivert</surname><given-names>M.</given-names></name><name><surname>Legros</surname><given-names>E.</given-names></name><name><surname>Defrance</surname><given-names>P.</given-names></name><name><surname>Belaiche</surname><given-names>J.</given-names></name><name><surname>Moonen</surname><given-names>G.</given-names></name><name><surname>Delwaide</surname><given-names>J.</given-names></name></person-group><article-title>Guillain-Barr&#x000e9; syndrome following hepatitis E</article-title><source>World J. Gastroenterol.</source><year>2009</year><volume>15</volume><fpage>1645</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.3748/wjg.15.1645</pub-id><pub-id pub-id-type="pmid">19340910</pub-id></element-citation></ref><ref id="B33-medsci-08-00009"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurissen</surname><given-names>I.</given-names></name><name><surname>Jeurissen</surname><given-names>A.</given-names></name><name><surname>Strauven</surname><given-names>T.</given-names></name><name><surname>Sprengers</surname><given-names>D.</given-names></name><name><surname>De Schepper</surname><given-names>B.</given-names></name></person-group><article-title>First case of anti-ganglioside GM1-positive Guillain-Barr&#x000e9; syndrome due to hepatitis e virus infection</article-title><source>Infection</source><year>2012</year><volume>40</volume><fpage>323</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1007/s15010-011-0185-6</pub-id><?supplied-pmid 21877179?><pub-id pub-id-type="pmid">21877179</pub-id></element-citation></ref><ref id="B34-medsci-08-00009"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salim</surname><given-names>O.J.</given-names></name><name><surname>Davidson</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Leach</surname><given-names>J.P.</given-names></name><name><surname>Heath</surname><given-names>C.</given-names></name></person-group><article-title>Brainstem encephalitis and acute polyneuropathy associated with hepatitis E infection</article-title><source>BMJ Case Rep.</source><year>2017</year><volume>2017</volume><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1136/bcr-2017-220799</pub-id><?supplied-pmid 28899886?><pub-id pub-id-type="pmid">28899886</pub-id></element-citation></ref><ref id="B35-medsci-08-00009"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>L.</given-names></name><name><surname>Mesquita</surname><given-names>J.</given-names></name><name><surname>Pereira</surname><given-names>N.R.</given-names></name><name><surname>Lima-Alves</surname><given-names>C.</given-names></name><name><surname>Serrao</surname><given-names>R.</given-names></name><name><surname>Figueiredo</surname><given-names>P.</given-names></name><name><surname>Reis</surname><given-names>J.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>J.</given-names></name><name><surname>Nascimento</surname><given-names>M.</given-names></name><name><surname>Sarmento</surname><given-names>A.</given-names></name></person-group><article-title>Acute hepatitis E complicated by Guillain-Barr&#x000e9; syndrome in Portugal, December 2012&#x02014;A case report</article-title><source>Eurosurveillance</source><year>2013</year><volume>18</volume><fpage>20563</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES2013.18.34.20563</pub-id><?supplied-pmid 23987830?><pub-id pub-id-type="pmid">23987830</pub-id></element-citation></ref><ref id="B36-medsci-08-00009"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharn</surname><given-names>N.</given-names></name><name><surname>Ganzenmueller</surname><given-names>T.</given-names></name><name><surname>Wenzel</surname><given-names>J.J.</given-names></name><name><surname>Dengler</surname><given-names>R.</given-names></name><name><surname>Heim</surname><given-names>A.</given-names></name><name><surname>Wegner</surname><given-names>F.</given-names></name></person-group><article-title>Guillain-Barr&#x000e9; syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c</article-title><source>Infection</source><year>2014</year><volume>42</volume><fpage>171</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1007/s15010-013-0448-5</pub-id><?supplied-pmid 23512540?><pub-id pub-id-type="pmid">23512540</pub-id></element-citation></ref><ref id="B37-medsci-08-00009"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>O.</given-names></name><name><surname>Poesen</surname><given-names>K.</given-names></name><name><surname>Saegeman</surname><given-names>V.</given-names></name><name><surname>Claeys</surname><given-names>K.G.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name></person-group><article-title>Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus&#x02013;Associated Guillain-Barr&#x000e9; Syndrome</article-title><source>JAMA Neurol.</source><year>2017</year><volume>74</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2016.3541</pub-id><pub-id pub-id-type="pmid">27820624</pub-id></element-citation></ref><ref id="B38-medsci-08-00009"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>B.V.D.</given-names></name><name><surname>Van Der Eijk</surname><given-names>A.A.</given-names></name><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Hunter</surname><given-names>J.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>Tio-Gillen</surname><given-names>A.P.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Jacobs</surname><given-names>B.C.</given-names></name></person-group><article-title>Guillain-Barre syndrome associated with preceding hepatitis E virus infection</article-title><source>Neurol.</source><year>2014</year><volume>82</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000111</pub-id></element-citation></ref><ref id="B39-medsci-08-00009"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China</article-title><source>EBioMedicine</source><year>2018</year><volume>36</volume><fpage>122</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.08.053</pub-id><pub-id pub-id-type="pmid">30190208</pub-id></element-citation></ref><ref id="B40-medsci-08-00009"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name></person-group><article-title>Guillain-Barre syndrome caused by hepatitis E infection: Case report and literature review</article-title><source>BMC Infect. Dis.</source><year>2018</year><volume>18</volume><elocation-id>50</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-018-2959-2</pub-id><pub-id pub-id-type="pmid">29357816</pub-id></element-citation></ref><ref id="B41-medsci-08-00009"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murkey</surname><given-names>J.A.</given-names></name><name><surname>Chew</surname><given-names>K.W.</given-names></name><name><surname>Carlson</surname><given-names>M.</given-names></name><name><surname>Shannon</surname><given-names>C.L.</given-names></name><name><surname>Sirohi</surname><given-names>D.</given-names></name><name><surname>Sample</surname><given-names>H.A.</given-names></name><name><surname>Wilson</surname><given-names>M.R.</given-names></name><name><surname>Vespa</surname><given-names>P.</given-names></name><name><surname>Humphries</surname><given-names>R.M.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing</article-title><source>Open Forum Infect. Dis.</source><year>2017</year><volume>4</volume><fpage>ofx121</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofx121</pub-id><?supplied-pmid 28721353?><pub-id pub-id-type="pmid">28721353</pub-id></element-citation></ref><ref id="B42-medsci-08-00009"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belbezier</surname><given-names>A.</given-names></name><name><surname>Deroux</surname><given-names>A.</given-names></name><name><surname>Sarrot-Reynauld</surname><given-names>F.</given-names></name><name><surname>Larrat</surname><given-names>S.</given-names></name><name><surname>Bouillet</surname><given-names>L.</given-names></name></person-group><article-title>Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman</article-title><source>Emerg. Infect. Dis.</source><year>2014</year><volume>20</volume><fpage>908</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.3201/eid2005.131551</pub-id><?supplied-pmid 24751295?><pub-id pub-id-type="pmid">24751295</pub-id></element-citation></ref><ref id="B43-medsci-08-00009"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belliere</surname><given-names>J.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Nogier</surname><given-names>M.B.</given-names></name><name><surname>Martinez</surname><given-names>S.</given-names></name><name><surname>Cintas</surname><given-names>P.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Lavayssi&#x000e8;re</surname><given-names>L.</given-names></name><name><surname>Cointault</surname><given-names>O.</given-names></name><name><surname>Faguer</surname><given-names>S.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient</article-title><source>Transpl. Infect. Dis.</source><year>2017</year><volume>19</volume><fpage>e12784</fpage><pub-id pub-id-type="doi">10.1111/tid.12784</pub-id></element-citation></ref><ref id="B44-medsci-08-00009"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despierres</surname><given-names>L.-A.</given-names></name><name><surname>Kaphan</surname><given-names>E.</given-names></name><name><surname>Shahram Attarian</surname><given-names>S.C.-B.</given-names></name><name><surname>Pelletier</surname><given-names>J.</given-names></name><name><surname>Pouget</surname><given-names>J.</given-names></name><name><surname>Motte</surname><given-names>A.</given-names></name><name><surname>Charrel</surname><given-names>R.</given-names></name><name><surname>Gerolami</surname><given-names>R.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name></person-group><article-title>Neurologic Disorders and Hepatitis E, France, 2010</article-title><source>J. Infect.</source><year>2011</year><volume>17</volume><fpage>1510</fpage><lpage>1513</lpage></element-citation></ref><ref id="B45-medsci-08-00009"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>A De Vries</surname><given-names>M.</given-names></name><name><surname>A Samijn</surname><given-names>J.P.</given-names></name><name><surname>De Man</surname><given-names>R.</given-names></name><name><surname>Boots</surname><given-names>J.M.M.</given-names></name></person-group><article-title>Hepatitis E-associated encephalopathy in a renal transplant recipient</article-title><source>BMJ Case Rep.</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1136/bcr-2014-204244</pub-id><?supplied-pmid 24789162?><pub-id pub-id-type="pmid">24789162</pub-id></element-citation></ref><ref id="B46-medsci-08-00009"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>A.K.</given-names></name><name><surname>Nijhawan</surname><given-names>S.</given-names></name><name><surname>Nepalia</surname><given-names>S.</given-names></name><name><surname>Suchismita</surname><given-names>A.</given-names></name></person-group><article-title>Association of Bell&#x02019;s Palsy with Hepatitis E Virus Infection: A Rare Entity</article-title><source>J. Clin. Exp. Hepatol.</source><year>2012</year><volume>2</volume><fpage>88</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S0973-6883(12)60082-6</pub-id><pub-id pub-id-type="pmid">25755411</pub-id></element-citation></ref><ref id="B47-medsci-08-00009"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazaki</surname><given-names>Y.</given-names></name><name><surname>Sugawara</surname><given-names>K.</given-names></name><name><surname>Honda</surname><given-names>M.</given-names></name><name><surname>Ohnishi</surname><given-names>H.</given-names></name><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Characteristics of 20 Patients with Autochthonous Acute Hepatitis E in Hokkaido, Japan: First Report of Bilateral Facial Palsy Following the Infection with Genotype 4 Hepatitis E Virus</article-title><source>Tohoku J. Exp. Med.</source><year>2015</year><volume>236</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1620/tjem.236.263</pub-id><pub-id pub-id-type="pmid">26228039</pub-id></element-citation></ref><ref id="B48-medsci-08-00009"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasha</surname><given-names>S.A.</given-names></name><name><surname>Pasha</surname><given-names>S.A.</given-names></name><name><surname>Suhasini</surname><given-names>T.</given-names></name><name><surname>Rao</surname><given-names>D.A.</given-names></name></person-group><article-title>Hepatitis E Virus-Associated Acute Encephalitic Parkinsonism</article-title><source>J. Assoc. Physicians India</source><year>2018</year><volume>66</volume><fpage>87</fpage><lpage>88</lpage></element-citation></ref><ref id="B49-medsci-08-00009"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>P.</given-names></name><name><surname>Morgan</surname><given-names>C.</given-names></name><name><surname>Ijaz</surname><given-names>S.</given-names></name></person-group><article-title>Transverse myelitis caused by hepatitis E: previously undescribed in adults</article-title><source>BMJ Case Rep.</source><year>2015</year><volume>2015</volume><fpage>2014</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1136/bcr-2014-209031</pub-id></element-citation></ref><ref id="B50-medsci-08-00009"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Gunson</surname><given-names>R.N.</given-names></name></person-group><article-title>Hepatitis E virus infection presenting with paraesthesia</article-title><source>Scott. Med J.</source><year>2015</year><volume>60</volume><fpage>e27</fpage><lpage>e29</lpage><pub-id pub-id-type="doi">10.1177/0036933015572093</pub-id><pub-id pub-id-type="pmid">25663032</pub-id></element-citation></ref><ref id="B51-medsci-08-00009"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mengel</surname><given-names>A.M.</given-names></name><name><surname>Stenzel</surname><given-names>W.</given-names></name><name><surname>Meisel</surname><given-names>A.</given-names></name><name><surname>B&#x000fc;ning</surname><given-names>C.</given-names></name></person-group><article-title>Hepatitis E-induced severe myositis</article-title><source>Muscle Nerve</source><year>2016</year><volume>53</volume><fpage>317</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1002/mus.24959</pub-id><pub-id pub-id-type="pmid">26514272</pub-id></element-citation></ref><ref id="B52-medsci-08-00009"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Cintas</surname><given-names>P.</given-names></name><name><surname>Garrouste</surname><given-names>C.</given-names></name><name><surname>Uro-Coste</surname><given-names>E.</given-names></name><name><surname>Cointault</surname><given-names>O.</given-names></name><name><surname>Rostaing</surname><given-names>L.</given-names></name></person-group><article-title>Hepatitis e virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis: Case report</article-title><source>Am. J. Transpl.</source><year>2010</year><volume>10</volume><fpage>1321</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2010.03068.x</pub-id><?supplied-pmid 20346067?><pub-id pub-id-type="pmid">20346067</pub-id></element-citation></ref><ref id="B53-medsci-08-00009"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blayney</surname><given-names>L.</given-names></name><name><surname>Morrish</surname><given-names>P.</given-names></name></person-group><article-title>Acute hepatitis E infection as a cause of unexplained neurological symptoms</article-title><source>BMJ Case Rep.</source><year>2018</year><volume>2018</volume><fpage>9</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1136/bcr-2018-224236</pub-id><?supplied-pmid 30018033?><pub-id pub-id-type="pmid">30018033</pub-id></element-citation></ref><ref id="B54-medsci-08-00009"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alpers</surname><given-names>E.C.</given-names></name><name><surname>Smith</surname><given-names>K.D.</given-names></name></person-group><article-title>Cryoglobulinemia and renal disease</article-title><source>Curr. Opin. Nephrol. Hypertens.</source><year>2008</year><volume>17</volume><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1097/MNH.0b013e3282f8afe2</pub-id><?supplied-pmid 18408474?><pub-id pub-id-type="pmid">18408474</pub-id></element-citation></ref><ref id="B55-medsci-08-00009"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marion</surname><given-names>O.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Del Bello</surname><given-names>A.</given-names></name><name><surname>Esposito</surname><given-names>L.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Puissant-Lubrano</surname><given-names>B.</given-names></name><name><surname>Alric</surname><given-names>L.</given-names></name><name><surname>Faguer</surname><given-names>S.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name></person-group><article-title>Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients</article-title><source>Liver Int.</source><year>2018</year><volume>38</volume><fpage>2178</fpage><lpage>2189</lpage><pub-id pub-id-type="doi">10.1111/liv.13894</pub-id><pub-id pub-id-type="pmid">29845733</pub-id></element-citation></ref><ref id="B56-medsci-08-00009"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Premkumar</surname><given-names>M.</given-names></name><name><surname>Rangegowda</surname><given-names>D.</given-names></name><name><surname>Vashishtha</surname><given-names>C.</given-names></name><name><surname>Bhatia</surname><given-names>V.</given-names></name><name><surname>Khumuckham</surname><given-names>J.S.</given-names></name><name><surname>Kumar</surname><given-names>B.</given-names></name></person-group><article-title>Acute Viral Hepatitis E Is Associated with the Development of Myocarditis</article-title><source>Case Rep. Hepatol.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2015/458056</pub-id></element-citation></ref><ref id="B57-medsci-08-00009"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>T.</given-names></name><name><surname>Bashir</surname><given-names>S.</given-names></name><name><surname>Adam</surname><given-names>M.K.J.</given-names></name><name><surname>Borum</surname><given-names>M.</given-names></name></person-group><article-title>Acute Myopericarditis due to Hepatitis E Virus Infection: The First Reported Case in the Western Hemisphere</article-title><source>J. Gastrointest. Dig. Syst.</source><year>2016</year><volume>6</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.4172/2161-069X.1000386</pub-id></element-citation></ref><ref id="B58-medsci-08-00009"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiqin</surname><given-names>Z.</given-names></name><name><surname>Dongming</surname><given-names>X.</given-names></name><name><surname>Kejun</surname><given-names>T.</given-names></name><name><surname>Yun</surname><given-names>Z.</given-names></name></person-group><article-title>Long Qt Syndrome and Torsades De Points in a Patient with Acute Hepatitis E Virus Infection: An Unusual Case</article-title><source>Hear.</source><year>2012</year><volume>98</volume><fpage>E222</fpage><lpage>E223</lpage><pub-id pub-id-type="doi">10.1136/heartjnl-2012-302920n.6</pub-id></element-citation></ref><ref id="B59-medsci-08-00009"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>J.</given-names></name><name><surname>Sen</surname><given-names>M.</given-names></name></person-group><article-title>Parvovirus B19-induced Thrombocytopenia and Anemia in a Child with Fatal Fulminant Hepatic Failure Coinfected with Hepatitis A and E Viruses</article-title><source>J. Trop. Pediatr.</source><year>2009</year><volume>55</volume><fpage>335</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1093/tropej/fmp004</pub-id><pub-id pub-id-type="pmid">19203989</pub-id></element-citation></ref><ref id="B60-medsci-08-00009"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saarwaani</surname><given-names>V.</given-names></name><name><surname>Prabhu</surname><given-names>M.</given-names></name><name><surname>Weena</surname><given-names>S.</given-names></name><name><surname>Saraschandra</surname><given-names>V.</given-names></name></person-group><article-title>Multiorgan Dysfunction from Hepatitis E infection</article-title><source>Crit. Care Med.</source><year>2017</year><volume>46</volume><fpage>240</fpage></element-citation></ref><ref id="B61-medsci-08-00009"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karki</surname><given-names>P.</given-names></name><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Mallick</surname><given-names>B.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Rana</surname><given-names>S.S.</given-names></name></person-group><article-title>Massive Hemolysis Causing Renal Failure in Acute Hepatitis E Infection</article-title><source>JCTH</source><year>2016</year><volume>4</volume><fpage>345</fpage><lpage>347</lpage><?supplied-pmid 28097104?><pub-id pub-id-type="pmid">28097104</pub-id></element-citation></ref><ref id="B62-medsci-08-00009"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deniel</surname><given-names>C.</given-names></name><name><surname>Coton</surname><given-names>T.</given-names></name><name><surname>Brardjanian</surname><given-names>S.</given-names></name><name><surname>Guisset</surname><given-names>M.</given-names></name><name><surname>Nicand</surname><given-names>E.</given-names></name><name><surname>Simon</surname><given-names>F.</given-names></name></person-group><article-title>Acute pancreatitis: A rare complication of acute hepatitis E</article-title><source>J. Clin. Virol.</source><year>2011</year><volume>51</volume><fpage>202</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2011.04.009</pub-id><?supplied-pmid 21628104?><pub-id pub-id-type="pmid">21628104</pub-id></element-citation></ref><ref id="B63-medsci-08-00009"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mithun</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>K.</given-names></name><name><surname>Ghoshal </surname><given-names>U.C.</given-names></name><name><surname>Saraswat</surname><given-names>V.A.</given-names></name><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Mohindra</surname><given-names>S.</given-names></name></person-group><article-title>Acute hepatitis E-associated acute pancreatitis a single center experience and literature review</article-title><source>Pancreas</source><year>2015</year><volume>44</volume><fpage>1320</fpage><lpage>1322</lpage><pub-id pub-id-type="pmid">26390412</pub-id></element-citation></ref><ref id="B64-medsci-08-00009"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>J.</given-names></name><name><surname>Stallmach</surname><given-names>A.</given-names></name><name><surname>Tannapfel</surname><given-names>A.</given-names></name><name><surname>Bruns</surname><given-names>T.</given-names></name></person-group><article-title>Acute-on-Chronic Liver Failure with Complicating Pancreatitis After Autochthonous Hepatitis E Infection</article-title><source>Zahedan J. Res. Med Sci.</source><year>2017</year><volume>17</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.5812/hepatmon.14039</pub-id></element-citation></ref><ref id="B65-medsci-08-00009"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>S.</given-names></name><name><surname>Jha</surname><given-names>R.</given-names></name><name><surname>Lakhtakia</surname><given-names>S.</given-names></name><name><surname>Narayan</surname><given-names>G.</given-names></name></person-group><article-title>Acute pancreatitis following kidney transplantation&#x02014;Role of viral infections</article-title><source>Clin. Transplant.</source><year>2003</year><volume>17</volume><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1034/j.1399-0012.2003.02041.x</pub-id><pub-id pub-id-type="pmid">12588319</pub-id></element-citation></ref><ref id="B66-medsci-08-00009"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somani</surname><given-names>S.K.</given-names></name><name><surname>Ghosh</surname><given-names>A.</given-names></name><name><surname>Awasthi</surname><given-names>G.</given-names></name></person-group><article-title>Severe acute pancreatitis with pseudocyst bleeding due to hepatitis e virus infection</article-title><source>Clin. J. Gastroenterol.</source><year>2009</year><volume>2</volume><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s12328-008-0035-y</pub-id><pub-id pub-id-type="pmid">26191807</pub-id></element-citation></ref><ref id="B67-medsci-08-00009"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>A.</given-names></name><name><surname>Basu</surname><given-names>P.P.</given-names></name></person-group><article-title>Acute Non-Fulminant Viral Hepatitis E Presenting with Acute Pancreatitis&#x02014;An Unusual Presentation</article-title><source>MJMS</source><year>2017</year><volume>24</volume><fpage>102</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.21315/mjms2017.24.4.12</pub-id><pub-id pub-id-type="pmid">28951695</pub-id></element-citation></ref><ref id="B68-medsci-08-00009"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujioka</surname><given-names>K.</given-names></name><name><surname>Nishimura</surname><given-names>T.</given-names></name><name><surname>Seki</surname><given-names>M.</given-names></name><name><surname>Kinoshita</surname><given-names>M.</given-names></name><name><surname>Mishima</surname><given-names>N.</given-names></name><name><surname>Irimajiri</surname><given-names>S.</given-names></name><name><surname>Yamato</surname><given-names>M.</given-names></name></person-group><article-title>Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case report</article-title><source>Trop. Med. Heal.</source><year>2016</year><volume>44</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/s41182-016-0016-7</pub-id></element-citation></ref><ref id="B69-medsci-08-00009"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumoulin</surname><given-names>F.L.</given-names></name><name><surname>Liese</surname><given-names>H.</given-names></name></person-group><article-title>Acute hepatitis E virus infection and autoimmune thyroiditis: yet another trigger?</article-title><source>BMJ Case Rep.</source><year>2012</year><volume>2012</volume><fpage>2011</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1136/bcr.12.2011.5441</pub-id></element-citation></ref><ref id="B70-medsci-08-00009"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallet</surname><given-names>V.</given-names></name><name><surname>Bruneau</surname><given-names>J.</given-names></name><name><surname>Zuber</surname><given-names>J.</given-names></name><name><surname>Alanio</surname><given-names>C.</given-names></name><name><surname>Leclerc-Mercier</surname><given-names>S.</given-names></name><name><surname>Roque-Afonso</surname><given-names>A.M.</given-names></name><name><surname>Kraft</surname><given-names>A.R.M.</given-names></name><name><surname>Couronn&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Roulot</surname><given-names>D.</given-names></name><name><surname>Wedemeyer</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder</article-title><source>J. Hepatol.</source><year>2017</year><volume>67</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2017.08.011</pub-id><pub-id pub-id-type="pmid">28625509</pub-id></element-citation></ref><ref id="B71-medsci-08-00009"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillebrandt</surname><given-names>K.H.</given-names></name><name><surname>Arsenic</surname><given-names>R.</given-names></name><name><surname>Hofmann</surname><given-names>J.</given-names></name><name><surname>Eurich</surname><given-names>D.</given-names></name><name><surname>G&#x000fc;l</surname><given-names>S.</given-names></name><name><surname>Str&#x000fc;cker</surname><given-names>B.</given-names></name><name><surname>Sauer</surname><given-names>I.M.</given-names></name><name><surname>Pratschke</surname><given-names>J.</given-names></name><name><surname>Stockmann</surname><given-names>M.</given-names></name><name><surname>Raschzok</surname><given-names>N.</given-names></name></person-group><article-title>Acute Graft Dysfunction 17 Years After Liver Transplant: A Challenging Clinical and Histologic Manifestation of Hepatitis E</article-title><source>Exp. Clin. Transplant.</source><year>2018</year><volume>16</volume><fpage>348</fpage><lpage>351</lpage><?supplied-pmid 27310664?><pub-id pub-id-type="pmid">27310664</pub-id></element-citation></ref><ref id="B72-medsci-08-00009"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Bello</surname><given-names>A.</given-names></name><name><surname>Guilbeau-Frugier</surname><given-names>C.</given-names></name><name><surname>Josse</surname><given-names>A.-G.</given-names></name><name><surname>Rostaing</surname><given-names>L.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name></person-group><article-title>Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin</article-title><source>Transpl. Infect. Dis.</source><year>2015</year><volume>17</volume><fpage>279</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1111/tid.12353</pub-id><?supplied-pmid 25708383?><pub-id pub-id-type="pmid">25708383</pub-id></element-citation></ref><ref id="B73-medsci-08-00009"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinault</surname><given-names>D.</given-names></name><name><surname>Ribes</surname><given-names>D.</given-names></name><name><surname>Delas</surname><given-names>A.</given-names></name><name><surname>Milongo</surname><given-names>D.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Puissant-Lubrano</surname><given-names>B.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name></person-group><article-title>Hepatitis E Virus&#x02013;Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person</article-title><source>Am. J. Kidney Dis.</source><year>2016</year><volume>67</volume><fpage>660</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2015.10.022</pub-id><pub-id pub-id-type="pmid">26682764</pub-id></element-citation></ref><ref id="B74-medsci-08-00009"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>H.K.</given-names></name><name><surname>Manjunath</surname><given-names>V.</given-names></name><name><surname>Umesh</surname><given-names>L.</given-names></name><name><surname>Kj</surname><given-names>K.</given-names></name><name><surname>Hc</surname><given-names>K.K.</given-names></name><name><surname>Vg</surname><given-names>M.</given-names></name><name><surname>L</surname><given-names>U.</given-names></name></person-group><article-title>Pleural effusion: A rare complication of co-infection of hepatitis A and hepatitis E</article-title><source>Ann. Trop. Med. Public Heal.</source><year>2012</year><volume>5</volume><fpage>532</fpage><pub-id pub-id-type="doi">10.4103/1755-6783.105156</pub-id></element-citation></ref><ref id="B75-medsci-08-00009"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Rostaing</surname><given-names>L.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name></person-group><article-title>Hepatitis E virus: Chronic infection, extra-hepatic manifestations, and treatment</article-title><source>Clin. Res. Hepatol Gastroenterol</source><year>2014</year><volume>39</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.clinre.2014.07.005</pub-id><?supplied-pmid 25150374?><pub-id pub-id-type="pmid">25168798</pub-id></element-citation></ref><ref id="B76-medsci-08-00009"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>B.N.</given-names></name><name><surname>Gulliver</surname><given-names>J.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name></person-group><article-title>Hepatitis E virus and neurological disorders</article-title><source>Pr. Neurol.</source><year>2017</year><volume>17</volume><fpage>282</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1136/practneurol-2016-001588</pub-id></element-citation></ref><ref id="B77-medsci-08-00009"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Van Eijk</surname><given-names>J.J.J.</given-names></name><name><surname>Mclean</surname><given-names>B.N.</given-names></name><name><surname>Cintas</surname><given-names>P.</given-names></name><name><surname>Bendall</surname><given-names>R.P.</given-names></name><name><surname>Jacobs</surname><given-names>B.C.</given-names></name></person-group><article-title>Hepatitis E virus and neurological injury</article-title><source>Nat. Rev. Neurol.</source><year>2016</year><volume>12</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2015.234</pub-id><pub-id pub-id-type="pmid">26711839</pub-id></element-citation></ref><ref id="B78-medsci-08-00009"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>L.M.</given-names></name><name><surname>Gridley</surname><given-names>G.</given-names></name><name><surname>Check</surname><given-names>D.</given-names></name><name><surname>Landgren</surname><given-names>O.</given-names></name></person-group><article-title>Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders</article-title><source>Blood</source><year>2008</year><volume>111</volume><fpage>3388</fpage><lpage>3394</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-10-121285</pub-id><pub-id pub-id-type="pmid">18239085</pub-id></element-citation></ref><ref id="B79-medsci-08-00009"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maso</surname><given-names>L.D.</given-names></name><name><surname>Franceschi</surname><given-names>S.</given-names></name></person-group><article-title>Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies</article-title><source>Cancer Epidemiol. Biomark. Prev.</source><year>2006</year><volume>15</volume><fpage>2078</fpage><lpage>2085</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-06-0308</pub-id></element-citation></ref><ref id="B80-medsci-08-00009"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shenoy</surname><given-names>R.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Kamath</surname><given-names>N.</given-names></name></person-group><article-title>Thrombocytopenia in hepatitis A--An atypical presentation</article-title><source>J. Trop. Pediatr.</source><year>2004</year><volume>50</volume><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1093/tropej/50.4.241</pub-id><pub-id pub-id-type="pmid">15357567</pub-id></element-citation></ref><ref id="B81-medsci-08-00009"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>S.B.</given-names></name><name><surname>Lee</surname><given-names>S.S.</given-names></name><name><surname>Jung</surname><given-names>H.C.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>T.H.</given-names></name><name><surname>Jung</surname><given-names>W.T.</given-names></name><name><surname>Lee</surname><given-names>O.J.</given-names></name><name><surname>Song</surname><given-names>D.H.</given-names></name></person-group><article-title>A Korean patient with Guillain-Barr&#x000e9; syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy</article-title><source>Clin. Mol. Hepatol.</source><year>2016</year><volume>22</volume><fpage>396</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.3350/cmh.2015.0039</pub-id><?supplied-pmid 27572076?><pub-id pub-id-type="pmid">27572076</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="medsci-08-00009-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>PRISMA diagram.</p></caption><graphic xlink:href="medsci-08-00009-g001"/></fig><table-wrap id="medsci-08-00009-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">medsci-08-00009-t001_Table 1</object-id><label>Table 1</label><caption><p>Extra-hepatic neurological and musculoskeletal manifestations of hepatitis E infection.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S. No</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disorder</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">First Author (Year, Study Design)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Patients</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guillain&#x02013;Barr&#x000e9; syndrome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Al-Saffar (2018, CR) [<xref rid="B25-medsci-08-00009" ref-type="bibr">25</xref>], Bandyopadhyay (2015, CR) [<xref rid="B26-medsci-08-00009" ref-type="bibr">26</xref>], Blasco-Perin * (2015, RS) [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>], Choudhary (2019, CR) [<xref rid="B27-medsci-08-00009" ref-type="bibr">27</xref>], Cronin (2011, CR) [<xref rid="B28-medsci-08-00009" ref-type="bibr">28</xref>], Fukae * (2016, CC) [<xref rid="B29-medsci-08-00009" ref-type="bibr">29</xref>], Higuchi (2015, CR) [<xref rid="B30-medsci-08-00009" ref-type="bibr">30</xref>], Ji (2016, CR) [<xref rid="B54-medsci-08-00009" ref-type="bibr">54</xref>], Lei (2017, CR) [<xref rid="B31-medsci-08-00009" ref-type="bibr">31</xref>], Loly (2009, CR) [<xref rid="B32-medsci-08-00009" ref-type="bibr">32</xref>], Maurissen (2012, CR) [<xref rid="B33-medsci-08-00009" ref-type="bibr">33</xref>], Salim (2017, CR) [<xref rid="B34-medsci-08-00009" ref-type="bibr">34</xref>], Santos (2012, CR) [<xref rid="B35-medsci-08-00009" ref-type="bibr">35</xref>], Scharn (2014, CR) [<xref rid="B36-medsci-08-00009" ref-type="bibr">36</xref>], Stevens (2015, RS) [<xref rid="B37-medsci-08-00009" ref-type="bibr">37</xref>], Van Den Berg (2014, CC) [<xref rid="B38-medsci-08-00009" ref-type="bibr">38</xref>], Wang (2018, CC) [<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>], Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>], Zheng (2018, CR) [<xref rid="B40-medsci-08-00009" ref-type="bibr">40</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neuralgic amyotrophy (Parsonage Turner syndrome/Brachial neuritis)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avila (2016, CR) [<xref rid="B9-medsci-08-00009" ref-type="bibr">9</xref>], Blasco-Perin (2015, RS) [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>], Dalton (2017, CSS) [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>]. Dartevel (2015, CS) [<xref rid="B12-medsci-08-00009" ref-type="bibr">12</xref>], Deroux (2014, CS) [<xref rid="B13-medsci-08-00009" ref-type="bibr">13</xref>], Fong (2009, CR) [<xref rid="B14-medsci-08-00009" ref-type="bibr">14</xref>], Frtiz (2018, CC) [<xref rid="B15-medsci-08-00009" ref-type="bibr">15</xref>], Jones (2017, RS) [<xref rid="B16-medsci-08-00009" ref-type="bibr">16</xref>], Sanchez-Azofra (2018, CR) [<xref rid="B17-medsci-08-00009" ref-type="bibr">17</xref>], Scanvion (2017, CR) [<xref rid="B18-medsci-08-00009" ref-type="bibr">18</xref>], Silva (2016, CR) [<xref rid="B19-medsci-08-00009" ref-type="bibr">19</xref>], Swinnen <sup>#</sup> (2018, CR) [<xref rid="B20-medsci-08-00009" ref-type="bibr">20</xref>], Theochari (2015, CR) [<xref rid="B21-medsci-08-00009" ref-type="bibr">21</xref>], Van Eijk (2014, Cohort) [<xref rid="B22-medsci-08-00009" ref-type="bibr">22</xref>], Velay (2017, CR) [<xref rid="B23-medsci-08-00009" ref-type="bibr">23</xref>], Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myasthenia gravis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Belbeizer (2014, CR) [<xref rid="B42-medsci-08-00009" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyneuromyopathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Belliere (2017, CR), [<xref rid="B43-medsci-08-00009" ref-type="bibr">43</xref>] Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mononeuritis multiplex</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blasco-Perin (2015, RS) [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meningo-radiculitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blasco-Perin (2015, RS), [<xref rid="B10-medsci-08-00009" ref-type="bibr">10</xref>] Despierres (2011, CS) [<xref rid="B44-medsci-08-00009" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-specific symptoms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blayney (2018, CR), [<xref rid="B53-medsci-08-00009" ref-type="bibr">53</xref>] Kamar (2010, CR) [<xref rid="B52-medsci-08-00009" ref-type="bibr">52</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cerebral ischemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dalton (2017, CSS), [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>] Wang (2018, CC) [<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epilepsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dalton (2017, CSS) [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dalton (2017, CSS) [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>], Deroux (2014, CS) [<xref rid="B13-medsci-08-00009" ref-type="bibr">13</xref>], Murkey (2017, CR) [<xref rid="B41-medsci-08-00009" ref-type="bibr">41</xref>], Wang (2018, CC) [<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Facial nerve palsy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dalton (2017, CSS) [<xref rid="B11-medsci-08-00009" ref-type="bibr">11</xref>], Jha (2012, CR) [<xref rid="B46-medsci-08-00009" ref-type="bibr">46</xref>], Yazaki (2015, CS) [<xref rid="B47-medsci-08-00009" ref-type="bibr">47</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalopathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">De Vries (2014, CR) [<xref rid="B45-medsci-08-00009" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Encephalitic Parkinsonism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pasha (2018, CR) [<xref rid="B48-medsci-08-00009" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Transverse myelitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sarkar (2015, CR) [<xref rid="B49-medsci-08-00009" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peripheral neuropathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bennet (2015, CR) [<xref rid="B50-medsci-08-00009" ref-type="bibr">50</xref>], Wang (2018, CC) [<xref rid="B39-medsci-08-00009" ref-type="bibr">39</xref>], Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vestibular neuritis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small fiber neuropathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myositis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mengel (2016, CR) [<xref rid="B51-medsci-08-00009" ref-type="bibr">51</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>CR: case report; RS: retrospective study; CC: Case-Control study; CS: Case Series; CSS: cross-sectional study; * one patient each was reported to have Miller-Fiser variant of Guillain&#x02013;Barr&#x000e9; syndrome; <sup>#</sup> report of a patient with anterior interosseous mono-neuropathy.</p></fn></table-wrap-foot></table-wrap><table-wrap id="medsci-08-00009-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">medsci-08-00009-t002_Table 2</object-id><label>Table 2</label><caption><p>Extra-hepatic cardiovascular and hematological manifestations of hepatitis E infection.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S. No</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disorder</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">First Author (Year, Study Design)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Patients</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiac Arrhythmia </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Long QT Syndrome and Torsade&#x02019;s de pointes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aiqin (2012, CR) [<xref rid="B58-medsci-08-00009" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myocarditis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dougherty (2016, CR) [<xref rid="B57-medsci-08-00009" ref-type="bibr">57</xref>], Premkumar (2015, CR) [<xref rid="B56-medsci-08-00009" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kishore (2009, CR) [<xref rid="B59-medsci-08-00009" ref-type="bibr">59</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thrombocytopenia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kishore (2009, CR) [<xref rid="B58-medsci-08-00009" ref-type="bibr">58</xref>], Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymphocytosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymphopenia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leukocytosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saarwaani (2017, CR) [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Massive hemolysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Karki (2016, CR) [<xref rid="B61-medsci-08-00009" ref-type="bibr">61</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monoclonal gammopathy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryoglobulinemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marion (2018, CC) [<xref rid="B55-medsci-08-00009" ref-type="bibr">55</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metabolic acidosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saarwaani (2017, CR) [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malignancies (Acute myeloid leukemia, plasmacytoma)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Woolson (2014, RS) [<xref rid="B24-medsci-08-00009" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr></tbody></table><table-wrap-foot><fn><p>CR: case report; RS: retrospective study; CC: case-control study.</p></fn></table-wrap-foot></table-wrap><table-wrap id="medsci-08-00009-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">medsci-08-00009-t003_Table 3</object-id><label>Table 3</label><caption><p>Miscellaneous extra-hepatic manifestations of hepatitis E infection.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">S. No</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Disorder</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">System</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">First Author (Year, Study Design)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of Patients</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Autoimmune Thyroiditis </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endocrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dumoulin (2012, CR) [<xref rid="B69-medsci-08-00009" ref-type="bibr">69</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cutaneous T-Cell lymphoproliferative disorder</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dermatology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mallet (2017, CR) [<xref rid="B70-medsci-08-00009" ref-type="bibr">70</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pancreatitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastro-intestinal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deniel (2011, CR) [<xref rid="B62-medsci-08-00009" ref-type="bibr">62</xref>], Mithun (2015, RS) [<xref rid="B63-medsci-08-00009" ref-type="bibr">63</xref>], Peter (2017, CR) [<xref rid="B64-medsci-08-00009" ref-type="bibr">64</xref>], Saarwaani (2017, CR) [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>], Sinha (2003, CS) [<xref rid="B65-medsci-08-00009" ref-type="bibr">65</xref>], Somani (2009, CR) [<xref rid="B66-medsci-08-00009" ref-type="bibr">66</xref>], Thakur (2017, CR) [<xref rid="B67-medsci-08-00009" ref-type="bibr">67</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pancreatic pseudocyst</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastro-intestinal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Somani (2009, CR) [<xref rid="B66-medsci-08-00009" ref-type="bibr">66</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acalculous cholecystitis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gastro-intestinal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fujioka (2016, CR) [<xref rid="B68-medsci-08-00009" ref-type="bibr">68</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute Graft Dysfunction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hillebrandt (2018, CR) [<xref rid="B71-medsci-08-00009" ref-type="bibr">71</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute Kidney Injury</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Karki (2016, CR) [<xref rid="B61-medsci-08-00009" ref-type="bibr">61</xref>], Saarwaani (2017, CR) [<xref rid="B60-medsci-08-00009" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cryoglobulinemic membranoproliferative glomerulonephritis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Del Bello (2015, CR) [<xref rid="B72-medsci-08-00009" ref-type="bibr">72</xref>], Guinault (2016, CR) [<xref rid="B73-medsci-08-00009" ref-type="bibr">73</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pleural Effusion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Respiratory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kumar (2012, CR) [<xref rid="B74-medsci-08-00009" ref-type="bibr">74</xref>] </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>No. of: Number of; CR: case report; RS: retrospective study; CS: case series.</p></fn></table-wrap-foot></table-wrap></floats-group></article>